反応式
Cl[C:2]1[CH:3]=[C:4]2[C:10]3([CH2:14][CH2:13][N:12]([CH2:15]/[CH:16]=[CH:17]/[C:18]4[CH:23]=[CH:22][C:21]([Cl:24])=[CH:20][CH:19]=4)[CH2:11]3)[CH2:9][NH:8][C:5]2=[CH:6][CH:7]=1.C(N(CC)CC)C.[Cl:32][C:33]1[CH:34]=[C:35]([CH:39]=[CH:40][N:41]=1)[C:36](Cl)=[O:37].C(=O)(O)[O-].[Na+]>ClCCl>[Cl:32][C:33]1[CH:34]=[C:35]([C:36]([N:8]2[C:5]3[C:4](=[CH:3][CH:2]=[CH:7][CH:6]=3)[C:10]3([CH2:14][CH2:13][N:12]([CH2:15]/[CH:16]=[CH:17]/[C:18]4[CH:23]=[CH:22][C:21]([Cl:24])=[CH:20][CH:19]=4)[CH2:11]3)[CH2:9]2)=[O:37])[CH:39]=[CH:40][N:41]=1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
A solution of 5-chloro-1′-[trans-3-(4-chlorophenyl)allyl]spiro[indoline-3,3′-pyrrolidine] (150 mg) and triethylamine (0.24 ml) in dichloromethane (5 ml) at 0° C. under argon was treated with 2-chloro-isonicotinoyl chloride (147 mg). The resulting solution was stirred at room temperature for 1 hour, poured into saturated aqueous sodium bicarbonate, extracted with ethyl acetate, dried (Na2SO4) and concentrated in vacuo. Silica gel chromatography of the residue (eluent cyclohexane:ethyl acetate 6:4) afforded the title compound, 1-(2-chloropyridin-4-yl)carbonyl-1′-[trans-3-(4-chlorophenyl)allyl]spiro[indoline-3,3′-pyrrolidine] (95 mg), which was characterised by its mass and NMR spectra. MS (ES+) 498/500 (M+H+).
後処理
- extractionextracted with ethyl acetate
- dry with materialdried (Na2SO4)
- concentrationconcentrated in vacuo
出典と根拠
- ORDレコード
- ord-274243220eae4859921604cb8134f577
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08846907B2
関連ノート
読み込み中…